Immunotherapy regimes dependent on ApoE status
US9644025B2 · kind B2 · utility
10Cited by
195References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 17, 2008 |
| Grant date | May 9, 2017 |
| Priority date | — |
| Expiry date | Feb 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of immunotherapy of Alzheimer's and similar diseases in which the regime administered to a patient depends on the ApoE genotype of the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.